Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cahayasakti Investindo Sukses Tbk. (CSIS) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Cahayasakti Investindo Sukses Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Cahayasakti Investindo Sukses Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Cahayasakti Investindo Sukses Tbk. trades at Rp202 (market cap 365.96B, 1.86M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Cahayasakti Investindo Sukses Tbk. is more actively traded (1.86M versus 843K). Which is the better fit depends on your goals.

CSISLABS
Market Cap
365.96B635.95B
Volume
1.86M843K
Lot
18.6K8.43K
Turnover
371.02M137.6M
Average Price
199.45163.22
Value
371.02M137.6M
Indicative Equilibrium Price
202165
Indicative Equilibrium Volume
54246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CSIS
View details
LABS
View details

About Cahayasakti Investindo Sukses Tbk.

PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.

Read more on CSIS

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS